サマリー

世界の胆嚢癌治療薬市場 2024-2028
胆嚢癌治療薬市場は2023-2028年に1億4,147万米ドルで成長し、予測期間中のCAGRは6.63%で加速すると予測されます。この調査レポートは、胆嚢癌治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、発展途上国における胆嚢がんの旺盛な発生率、胆嚢がんのリスク要因、胆嚢がん治療のための免疫療法の登場によって牽引されています。
Technavioの胆嚢がん治療薬市場は以下のようにセグメント化されています：
タイプ別
- 併用療法
- 単剤療法
用途別
- 病院
- 大学・医療センター
- その他
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、胆嚢癌の強力なパイプラインが、今後数年間の胆嚢癌治療薬市場の成長を促進する主要な理由の1つであると特定している。また、免疫療法や次世代シークエンシング（NGS）ベースの検査の採用が増加していることも、同市場における大規模な需要につながるでしょう。
この調査レポートは、胆嚢癌治療薬市場を調査・分析し、以下のてこ入れを行っています：
- 胆嚢癌治療薬市場のサイジング
- 胆嚢癌治療薬市場予測
- 胆嚢癌治療薬市場産業分析
強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AbbVie Inc.、AstraZeneca Plc、B.Braun SE、Boston Scientific Corp、Bristol Myers Squibb Co.、Conmed Corp.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc.、Medtronic Plc、Merck KGaA、Novartis AG、Olympus Corp.、Pfizer Inc.、Sanofi SA、Smith and Nephew plc、Sun Pharmaceutical Industries Ltd.などです。また、胆嚢癌治療薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、包括的な市場およびベンダーの状況と主要ベンダーの分析が含まれています。本レポートの詳細については、https://www.technavio.com/report/gallbladder-cancer-therapeutics-market-industry-size-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global gallbladder cancer therapeutics market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global gallbladder cancer therapeutics market 2018 - 2022 ($ million)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
o 4.3 Application Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Combination therapy - Market size and forecast 2023-2028
o Exhibit 34: Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
o 6.4 Monotherapy - Market size and forecast 2023-2028
o Exhibit 38: Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Application - Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Hospitals - Market size and forecast 2023-2028
o Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
o 7.4 Academic and medical centers - Market size and forecast 2023-2028
o Exhibit 52: Chart on Academic and medical centers - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Academic and medical centers - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Academic and medical centers - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Academic and medical centers - Year-over-year growth 2023-2028 (%)
o 7.5 Others - Market size and forecast 2023-2028
o Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Application
o Exhibit 60: Market opportunity by Application ($ million)
o Exhibit 61: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2023-2028 (%)
o Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 UK - Market size and forecast 2023-2028
o Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 India - Market size and forecast 2023-2028
o Exhibit 99: Chart on India - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on India - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on India - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on India - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. - Overview
o Exhibit 112: AbbVie Inc. - Product / Service
o Exhibit 113: AbbVie Inc. - Key news
o Exhibit 114: AbbVie Inc. - Key offerings
o 12.4 B.Braun SE
o Exhibit 115: B.Braun SE - Overview
o Exhibit 116: B.Braun SE - Business segments
o Exhibit 117: B.Braun SE - Key news
o Exhibit 118: B.Braun SE - Key offerings
o Exhibit 119: B.Braun SE - Segment focus
o 12.5 Boston Scientific Corp.
o Exhibit 120: Boston Scientific Corp. - Overview
o Exhibit 121: Boston Scientific Corp. - Business segments
o Exhibit 122: Boston Scientific Corp. - Key news
o Exhibit 123: Boston Scientific Corp. - Key offerings
o Exhibit 124: Boston Scientific Corp. - Segment focus
o 12.6 Bristol Myers Squibb Co.
o Exhibit 125: Bristol Myers Squibb Co. - Overview
o Exhibit 126: Bristol Myers Squibb Co. - Product / Service
o Exhibit 127: Bristol Myers Squibb Co. - Key news
o Exhibit 128: Bristol Myers Squibb Co. - Key offerings
o 12.7 Conmed Corp.
o Exhibit 129: Conmed Corp. - Overview
o Exhibit 130: Conmed Corp. - Business segments
o Exhibit 131: Conmed Corp. - Key offerings
o Exhibit 132: Conmed Corp. - Segment focus
o 12.8 Eli Lilly and Co.
o Exhibit 133: Eli Lilly and Co. - Overview
o Exhibit 134: Eli Lilly and Co. - Product / Service
o Exhibit 135: Eli Lilly and Co. - Key news
o Exhibit 136: Eli Lilly and Co. - Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
o 12.10 Gilead Sciences Inc.
o Exhibit 142: Gilead Sciences Inc. - Overview
o Exhibit 143: Gilead Sciences Inc. - Product / Service
o Exhibit 144: Gilead Sciences Inc. - Key news
o Exhibit 145: Gilead Sciences Inc. - Key offerings
o 12.11 Medtronic Plc
o Exhibit 146: Medtronic Plc - Overview
o Exhibit 147: Medtronic Plc - Business segments
o Exhibit 148: Medtronic Plc - Key news
o Exhibit 149: Medtronic Plc - Key offerings
o Exhibit 150: Medtronic Plc - Segment focus
o 12.12 Novartis AG
o Exhibit 151: Novartis AG - Overview
o Exhibit 152: Novartis AG - Business segments
o Exhibit 153: Novartis AG - Key offerings
o Exhibit 154: Novartis AG - Segment focus
o 12.13 Olympus Corp.
o Exhibit 155: Olympus Corp. - Overview
o Exhibit 156: Olympus Corp. - Business segments
o Exhibit 157: Olympus Corp. - Key news
o Exhibit 158: Olympus Corp. - Key offerings
o Exhibit 159: Olympus Corp. - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 160: Pfizer Inc. - Overview
o Exhibit 161: Pfizer Inc. - Product / Service
o Exhibit 162: Pfizer Inc. - Key news
o Exhibit 163: Pfizer Inc. - Key offerings
o 12.15 Sanofi SA
o Exhibit 164: Sanofi SA - Overview
o Exhibit 165: Sanofi SA - Business segments
o Exhibit 166: Sanofi SA - Key news
o Exhibit 167: Sanofi SA - Key offerings
o Exhibit 168: Sanofi SA - Segment focus
o 12.16 Smith and Nephew plc
o Exhibit 169: Smith and Nephew plc - Overview
o Exhibit 170: Smith and Nephew plc - Business segments
o Exhibit 171: Smith and Nephew plc - Key news
o Exhibit 172: Smith and Nephew plc - Key offerings
o Exhibit 173: Smith and Nephew plc - Segment focus
o 12.17 Sun Pharmaceutical Industries Ltd.
o Exhibit 174: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 175: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 176: Sun Pharmaceutical Industries Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global gallbladder cancer therapeutics market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Combination therapy - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Combination therapy - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Monotherapy - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Monotherapy - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Application - Market share 2023-2028 (%)
Exhibits45: Data Table on Application - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Academic and medical centers - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Academic and medical centers - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Academic and medical centers - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Academic and medical centers - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2023-2028 (%)
Exhibits64: Data Table on Market share by geography 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: B.Braun SE - Overview
Exhibits116: B.Braun SE - Business segments
Exhibits117: B.Braun SE - Key news
Exhibits118: B.Braun SE - Key offerings
Exhibits119: B.Braun SE - Segment focus
Exhibits120: Boston Scientific Corp. - Overview
Exhibits121: Boston Scientific Corp. - Business segments
Exhibits122: Boston Scientific Corp. - Key news
Exhibits123: Boston Scientific Corp. - Key offerings
Exhibits124: Boston Scientific Corp. - Segment focus
Exhibits125: Bristol Myers Squibb Co. - Overview
Exhibits126: Bristol Myers Squibb Co. - Product / Service
Exhibits127: Bristol Myers Squibb Co. - Key news
Exhibits128: Bristol Myers Squibb Co. - Key offerings
Exhibits129: Conmed Corp. - Overview
Exhibits130: Conmed Corp. - Business segments
Exhibits131: Conmed Corp. - Key offerings
Exhibits132: Conmed Corp. - Segment focus
Exhibits133: Eli Lilly and Co. - Overview
Exhibits134: Eli Lilly and Co. - Product / Service
Exhibits135: Eli Lilly and Co. - Key news
Exhibits136: Eli Lilly and Co. - Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. - Overview
Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
Exhibits139: F. Hoffmann La Roche Ltd. - Key news
Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits142: Gilead Sciences Inc. - Overview
Exhibits143: Gilead Sciences Inc. - Product / Service
Exhibits144: Gilead Sciences Inc. - Key news
Exhibits145: Gilead Sciences Inc. - Key offerings
Exhibits146: Medtronic Plc - Overview
Exhibits147: Medtronic Plc - Business segments
Exhibits148: Medtronic Plc - Key news
Exhibits149: Medtronic Plc - Key offerings
Exhibits150: Medtronic Plc - Segment focus
Exhibits151: Novartis AG - Overview
Exhibits152: Novartis AG - Business segments
Exhibits153: Novartis AG - Key offerings
Exhibits154: Novartis AG - Segment focus
Exhibits155: Olympus Corp. - Overview
Exhibits156: Olympus Corp. - Business segments
Exhibits157: Olympus Corp. - Key news
Exhibits158: Olympus Corp. - Key offerings
Exhibits159: Olympus Corp. - Segment focus
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Sanofi SA - Overview
Exhibits165: Sanofi SA - Business segments
Exhibits166: Sanofi SA - Key news
Exhibits167: Sanofi SA - Key offerings
Exhibits168: Sanofi SA - Segment focus
Exhibits169: Smith and Nephew plc - Overview
Exhibits170: Smith and Nephew plc - Business segments
Exhibits171: Smith and Nephew plc - Key news
Exhibits172: Smith and Nephew plc - Key offerings
Exhibits173: Smith and Nephew plc - Segment focus
Exhibits174: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits175: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits176: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations